Intelligence · Clinical Pipeline
Ultragenyx UK Pipeline
All ClinicalTrials.gov programs at Ultragenyx UK — phase, modality, and trial IDs.
- Programs
- 5
Quick answer
Ultragenyx UK has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Crysvita (burosumab-twza) Treatment
Ultragenyx UK Limited
Epidermal Nevus Syndrome
1 trial -
Leucovorin calcium
Ultragenyx UK Limited
Toxoplasmosis
1 trial -
Osilodrostat (Isturisa)
Ultragenyx UK Limited
Mild Autonomous Cortisol Secretion (MACS)
1 trial -
epoprostenol
Ultragenyx UK Limited
Hypertension, Pulmonary
1 trial -
miglustat
Ultragenyx UK Limited
GM1 Gangliosidoses
1 trial
Frequently asked questions
How many pipeline programs does Ultragenyx UK have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs